Evidence map›Paper›PMID 40250187›Full record

ArticleInternational journal of surgery case reports2025

A rare case of desmoplastic medulloblastoma in a 65-year-old male: A case report on achieving stability post-grade IV surgical resection.

Mohammad Obada Alsadi, Massa Saker, Sara Elias, Tareq Kaelooh, Asmaa Alrefai, Mohammad Sattouf

Abstract readCase Reports
In one paragraph

Article in International journal of surgery case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mohammad Obada AlsadiDamascus University, Faculty of Medicine, Damascus, Syrian Arab Republic. Electronic address: obadaalsadi7@gmail.com.
Massa SakerDamascus University, Faculty of Medicine, Damascus, Syrian Arab Republic.
Sara EliasDamascus University, Faculty of Medicine, Damascus, Syrian Arab Republic.
Tareq KaeloohHoms University, Faculty of Medicine, Homs, Syrian Arab Republic.
Asmaa AlrefaiHoms University, Faculty of Medicine, Homs, Syrian Arab Republic.
Mohammad SattoufNeurosurgery Department at National University Hospital, Damascus University, Damascus, Syrian Arab Republic. Electronic address: mohammad.sattouf@damascusuniversity.edu.sy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMedulloblastoma (MB) is an aggressive cerebellar tumor. In adults, it mainly occurs in the cerebellar hemispheres with desmoplastic traits, constituting 0.4 %-1 % of central nervous system tumors, primarily affecting individuals under 40. Cases above 60 are rare. Recent treatments have improved prognosis, with a 75 %-80 % five-year survival rate. CASE PRESENTATION: A 65-year-old man with no medical history presented with intermittent vertigo, progressive headaches, and morning nausea. MRI showed an enhancing desmoplastic medulloblastoma (WHO Grade IV) in the right cerebellar hemisphere. Successful total excision was performed without neurological deficits. Pathology confirmed the diagnosis, followed by chemotherapy and radiotherapy. Postoperative MRI showed complete resection with no spinal metastases. Over four years, the patient remained asymptomatic and stable. DISCUSSION: Medulloblastoma is rare in adults, presenting with cerebellar dysfunction and elevated intracranial pressure. Imaging and multimodal treatment, including surgery and adjuvant therapy, ensure improved outcomes, as seen in our patient's long-term remission.

conclusionThis case highlights the importance of considering medulloblastoma in differential diagnoses for older patients with cerebellar symptoms and the success of multimodality treatment.

Indexed as

AdultDesmoplasticGrade IVMedulloblastoma

Identifiers

PMID40250187
PMCPMC12033905

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.